Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAP Advance Auto Parts	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.37 -24.6%	$43.00
AAP Advance Auto Parts	Target Set by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.37 -24.6%	$45.00
ABBV AbbVie	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$261.88 -1.5%	$298.00 ➝ $303.00	Overweight
ACDC ProFrac	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Laetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.44 -5.5%	$5.00 ➝ $4.50	Underweight
ACIU AC Immune	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Shrader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.64 +2.3%	$8.00	Buy
ACOG Alpha Cognition	Initiated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Woods Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.50 +6.9%	$21.00	Buy
ADI Analog Devices	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	N. Quinn Bolton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.24 -0.8%	$440.00 ➝ $450.00	Buy
ADI Analog Devices	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Harlan Sur Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.24 -0.8%	$450.00 ➝ $500.00	Overweight
ADI Analog Devices	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.24 -0.8%	$460.00	Buy
ADI Analog Devices	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Quatrochi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.24 -0.8%	$515.00 ➝ $500.00	Overweight
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADI Analog Devices	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Moore Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$370.24 -0.8%	$428.00 ➝ $458.00	Overweight
ADI Analog Devices	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$370.24 -0.8%	$430.00	Outperform
ADSK Autodesk	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.02 -0.1%	$245.00 ➝ $277.00	Buy
ADSK Autodesk	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.02 -0.1%	$252.00 ➝ $269.00	Neutral
ADSK Autodesk	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$251.02 -0.1%	$277.00
AII American Integrity Insurance Group	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.34 +1.9%	$27.00
ALIT Alight	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Christiansen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.40 -2.7%	$20.00 ➝ $16.00	Neutral
ALIT Alight	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.40 -2.7%		Hold
ALL Allstate	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$254.29 -2.1%	$255.00 ➝ $250.00	Market Perform ➝ Underperform
AMBP Ardagh Metal Packaging	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.28 +1.0%	$5.20	Hold
AMD Advanced Micro Devices	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$469.45 +0.6%	$550.00	Outperform
AMGN Amgen	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$433.73 -2.0%	$427.00 ➝ $457.00	Overweight
AMR Alpha Metallurgical Resources	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nick Giles Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$193.85 -0.3%	$189.00 ➝ $185.00	Neutral
AMT American Tower	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhorta Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$175.99 +0.9%	$208.00
AMTM Amentum	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.62 -1.9%	$24.00
AMZN Amazon.com	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$259.92 -2.2%	$335.00	Buy
ANTA Antalpha Platform	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Hal Goetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.91 -3.5%	$9.50 ➝ $7.50	Buy
APA APA	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$44.39 +2.2%	$38.00 ➝ $44.00	Neutral
ASST Strive	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.13 +9.5%		Buy
ATD Alimentation Couche-Tard	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$86.05 -2.2%	C$110.00 ➝ C$108.00	Buy
AVGO Broadcom	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$364.03 +0.4%	$455.00	Outperform
AYA Aya Gold & Silver	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$37.09 -1.3%	C$41.00 ➝ C$43.00	Outperform
BABA Alibaba Group	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$130.25 +1.0%		Buy
BAND Bandwidth	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Reilly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.15 -7.9%		Buy
BAP Credicorp	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thiago Batista Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$371.16 +0.6%	$412.00 ➝ $473.00	Buy
BBY Best Buy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.67 -4.0%	$77.00 ➝ $85.00	Neutral
BCAL California BanCorp	Initiated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.20 +0.7%	$25.00	Outperform
BILL BILL	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Quintero Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$55.00 ➝ $60.00	Equal Weight
BILL BILL	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$50.00 ➝ $57.00	Buy
BILL BILL	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$47.26 -0.9%		Buy
Major Buy Alert Issued for August 31st (Ad) Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 people worldwide. His system has flagged a handful of stocks worth watching ahead of August 31st. See which stocks his AI research platform is flagging right now. See which stocks his AI research platform is flagging now
BILL BILL	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samad Samana Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$50.00 ➝ $56.00	Buy
BILL BILL	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Jester Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$46.00 ➝ $55.00	Market Perform
BILL BILL	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$55.00 ➝ $60.00	Buy
BILL BILL	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sanjay Sakhrani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$46.00 ➝ $54.00	Market Perform
BILL BILL	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Harte Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.26 -0.9%	$60.00	Buy
BRT BRT Apartments	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.61 +0.6%	$20.00	Market Outperform
BRT BRT Apartments	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.61 +0.6%		Market Outperform
BTDR Bitdeer Technologies Group	Initiated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Cremo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.43 +8.3%	$15.00	Overweight
BULL Webull	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.85 +2.4%	$13.00 ➝ $15.00	Buy
BWLP BW LPG	Upgraded by	Clarkson Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.43 +0.5%		Neutral ➝ Buy
CDXS Codexis	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.58 -1.3%		Hold
CGEMY Cap Gemini	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.53 -0.6%		Hold
CGS Castings	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 312 +4.0%	GBX 390	Buy
CHWY Chewy	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.79 -0.8%	$25.00	Neutral
CIEN Ciena	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tal Liani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.08 -1.6%		Buy
COF Capital One Financial	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$212.55 -3.7%	$245.00
COTY Coty	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Modi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.75 -9.2%	$3.00	Outperform ➝ Sector Perform
COTY Coty	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.75 -9.2%	$2.60	Neutral
CPB Campbell's	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.77 -0.2%	$17.00 ➝ $18.00	Sell
CPRT Copart	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeff Lick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.33 +1.4%	$35.00	Equal Weight
CRM Salesforce	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew VanVliet Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.61 -0.2%	$250.00	Overweight
CRM Salesforce	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.61 -0.2%	$228.00	Buy
CRM Salesforce	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$205.61 -0.2%	$215.00 ➝ $230.00	Outperform
CRM Salesforce	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$205.61 -0.2%		Outperform
CRTO Criteo	Target Lowered by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.49 -2.0%	$30.00 ➝ $25.00	Outperform
CRVO CervoMed	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boobalan Pachaiyappan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.56 -5.5%	$7.00
CTEV Claritev	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.97 -4.0%	$40.00	Overweight
CTL CleanTech Lithium	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 6 +4.3%	GBX 17	Speculative Buy
DASH DoorDash	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.36 +1.0%	$205.00 ➝ $220.00	Neutral
DE Deere & Company	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Noah Kaye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$624.38 +7.5%		Outperform
DOL Dollarama	Target Set by	Ventum Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$187.30 -1.4%	C$225.00	Buy
DOO BRP	Target Raised by	National Bank Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$92.03 -2.3%	C$84.00 ➝ C$98.00	Sector Perform
DRD DRDGOLD	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.61 +6.4%	$33.00 ➝ $35.00	Buy
DRUG Bright Minds Biosciences	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$78.56 -7.3%		Buy
DRUG Bright Minds Biosciences	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$78.56 -7.3%		Market Perform
DUOL Duolingo	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.03 +0.7%	$139.00 ➝ $150.00	Neutral
EBAY eBay	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.61 +1.9%	$135.00 ➝ $137.00	Outperform
EBAY eBay	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$104.61 +1.9%	$120.00	Buy
ECG Everus Construction Group	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kurt Yinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.71 -3.7%	$168.00
EGO Eldorado Gold	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.75 +2.4%		Buy
EL Estee Lauder Companies	Target Raised by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sydney Wagner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$88.00 ➝ $100.00	Hold
EL Estee Lauder Companies	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Susan Anderson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$85.00 ➝ $90.00	Hold
EL Estee Lauder Companies	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$90.00 ➝ $100.00	Hold
EL Estee Lauder Companies	Reiterated by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Glaessgen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$85.00 ➝ $100.00	Neutral
EL Estee Lauder Companies	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$95.00 ➝ $115.00	Overweight
EL Estee Lauder Companies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christopher Carey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$85.00 ➝ $104.00	Equal Weight
EL Estee Lauder Companies	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bonnie Herzog Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$100.00 ➝ $112.00	Buy
EL Estee Lauder Companies	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrea Teixeira Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$94.00 ➝ $112.00	Overweight
EL Estee Lauder Companies	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$90.00 ➝ $108.00	Market Perform
EL Estee Lauder Companies	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$110.00 ➝ $115.00	Buy
These 3 Stocks Could Soar as Sam Altman Announces New Venture After OpenAI (Ad) Elon Musk calls it the most disruptive force in history. Sam Altman is reportedly preparing a new venture after OpenAI, one some say could be 500 times bigger than ChatGPT. Test staff are said to be bound by law to keep details secret, and three lesser-known stocks may be tied to this next chapter in AI. Click here to see the stocks linked to Altman's next big move
EL Estee Lauder Companies	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$90.00 ➝ $102.00	Equal Weight
EL Estee Lauder Companies	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.98 -2.1%	$86.00 ➝ $106.00	Neutral
EQH Equitable	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$48.75 -2.4%	$66.00	Outperform
EQPT EquipmentShare.com	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Fisher Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.27 -7.2%	$24.00 ➝ $22.00	Neutral
ESTC Elastic	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.62 -2.0%	$80.00 ➝ $100.00	Buy
ETN Eaton	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$416.05 -2.0%	$500.00
ETOR eToro Group	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Vafi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.67 +4.1%	$65.00 ➝ $53.00	Buy
ETSY Etsy	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Nagle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.30 +1.0%	$88.00 ➝ $95.00	Neutral ➝ Buy
ETSY Etsy	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Davis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.30 +1.0%	$95.00	Buy
ETSY Etsy	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Feather Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.30 +1.0%		Underweight ➝ Outperform
ETSY Etsy	Upgraded by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nikhil Devnani Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.30 +1.0%		Market Perform ➝ Outperform
ETSY Etsy	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.30 +1.0%		Sector Perform
ETSY Etsy	Target Set by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$81.30 +1.0%	$105.00
EWTX Edgewise Therapeutics	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tessa Romero Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.29 -6.8%	$53.00 ➝ $60.00	Overweight
EXPE Expedia Group	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$324.17 -0.6%	$334.00 ➝ $417.00	Outperform
FDY Faraday Copper	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$5.32 -2.0%	C$7.00	Buy
FIGR Figure Technology Solutions	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.06 -2.1%	$55.00	Buy
FISV Fiserv	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Coad Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$51.38 -1.3%	$52.00 ➝ $53.00	Hold
FIX Comfort Systems USA	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Chan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1,674.43 -1.3%	$2,100.00
FLNC Fluence Energy	Downgraded by	Glj Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gordon L. Johnson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.39 -5.6%	$26.00 ➝ $12.89	Buy ➝ Hold
FOX FOX	Target Set by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$60.45 +0.1%	$93.00
FRNM Freenome	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.51 -0.9%	$21.00	Buy
GAP GAP	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brooke Roach Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.67 -2.1%	$25.00	Buy
GBFH GBank Financial	Reiterated by	JonesTrading Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Erdner Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.75 -0.1%	$35.00	Buy
GDRX GoodRx	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.56 +0.6%	$4.00	Underweight
GEMI Gemini Space Station	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Christiansen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$4.14 +5.3%	$4.00 ➝ $3.20	Sell
GGB Gerdau	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.34 -2.7%	$5.10	Buy ➝ Neutral
GKOS Glaukos	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$185.25 -2.3%	$193.00 ➝ $202.00	Buy
GOOG Alphabet	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$338.20 -1.0%		Buy
GOOGL Alphabet	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$340.67 -1.2%	$410.00	Buy
GTLB GitLab	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.08 -1.2%	$30.00 ➝ $40.00	Hold
HAS Hasbro	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Bonadio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$93.56 +0.2%	$85.00 ➝ $90.00	Equal Weight
HCA HCA Healthcare	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Rossi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$406.33 -0.2%	$490.00 ➝ $425.00	Neutral
HCAT Health Catalyst	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Close Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.63 -3.6%	$1.80
HELP Cybin	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ritu Baral Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.47 +5.9%	$8.00 ➝ $62.00	Buy
HIVE HIVE Digital Technologies	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Brendler Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.13 +11.0%	$5.50 ➝ $6.00	Buy
HL Hecla Mining	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.87 +1.6%		Hold
HNHPF Hon Hai Precision Industry Co., Ltd. Sponsored GDR	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.44 -0.5%	$23.00	Overweight
HP Helmerich & Payne	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Laetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.92 +0.4%	$36.00 ➝ $41.00	Underweight
HSHP Himalaya Shipping	Upgraded by	Clarkson Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.02		Neutral ➝ Buy
HUBB Hubbell	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$470.45 -1.1%	$550.00
HUN Huntsman	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.14 -0.4%	$11.00	Hold
HYPR Hyperfine	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Marie Thibault Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.90 +0.3%	$2.00	Buy
IAG Iamgold	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$20.50 +4.0%		Hold ➝ Buy
INCY Incyte	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$127.22 -1.0%		Buy
INCY Incyte	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.22 -1.0%	$150.00	Buy
INCY Incyte	Initiated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Newman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.22 -1.0%	$152.00	Buy
IOT Samsara	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$38.93 -0.7%	$45.00 ➝ $48.00	Buy
IOVA Iovance Biotherapeutics	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Dai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.99 +12.5%	$4.00 ➝ $7.00	Neutral
IQ iQIYI	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.03 -8.8%	$1.40	Neutral
Did you see this? (Ad) Joel Peterson's 75-minute Crypto Code workshop is now live as a replay. Twenty minutes in, he puts his real trading accounts on screen and walks through them year by year, not screenshots or slides. The trade record is publicly verifiable, and the $10 Bitcoin gift is still active for viewers who watch the replay. This session on tackling crypto trading with a plan instead of guesswork won't stay up indefinitely. Watch the full workshop replay now before it comes down.
IQ iQIYI	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03 -8.8%	$2.20 ➝ $1.20	Neutral
JD JD Sports Fashion	Reiterated by	Shore Capital Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 93.46 +2.1%	GBX 75	Hold
JKHY Jack Henry & Associates	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel R. Perlin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.08 +1.2%	$173.00 ➝ $178.00	Outperform
JKHY Jack Henry & Associates	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Will Nance Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.08 +1.2%	$158.00 ➝ $178.00	Neutral
JKHY Jack Henry & Associates	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nik Cremo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.08 +1.2%	$170.00 ➝ $185.00	Overweight
JKHY Jack Henry & Associates	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Chiodo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$165.08 +1.2%	$165.00 ➝ $170.00	Neutral
KDP Keurig Dr Pepper	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dara Mohsenian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$31.66 +1.9%	$38.00	Overweight
KIDS OrthoPediatrics	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.23 -1.0%	$24.00 ➝ $29.00	Buy
KMR Kenmare Resources	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 205 -1.4%	GBX 220 ➝ GBX 210	Hold
KRRO Korro Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.96 -7.1%	$15.00	Buy
LILA Liberty Latin America	Downgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cesar Medina Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.17 -2.0%	$7.00	Equal Weight ➝ Underweight
LIME Neutron	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Boone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$42.03 +11.4%	$45.00	Market Outperform
LIME Neutron	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$42.03 +11.4%		Market Outperform
LNSR LENSAR	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.44 -3.2%	$9.00 ➝ $10.00	Buy
LOGI Logitech International	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Cardoso Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$95.34 -5.1%	$120.00 ➝ $102.00	Neutral
LOW Lowe's Companies	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Zaccone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$267.00 ➝ $260.00	Buy
LOW Lowe's Companies	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$217.72 -1.0%		Overweight
LOW Lowe's Companies	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$255.00 ➝ $254.00	Buy
LOW Lowe's Companies	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$285.00 ➝ $275.00	Buy
LOW Lowe's Companies	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$231.00	Sector Perform
LOW Lowe's Companies	Target Lowered by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$280.00 ➝ $260.00	Outperform
LOW Lowe's Companies	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Max Rakhlenko Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$235.00	Hold
LOW Lowe's Companies	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Bellinger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$280.00 ➝ $250.00	Outperform
LOW Lowe's Companies	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley B. Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$217.72 -1.0%	$275.00	Overweight
LUN Lundin Mining	Target Lowered by	Desjardins Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$36.11 +2.4%	C$44.00 ➝ C$42.00	Buy
LWAY Lifeway Foods	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.91 +3.5%	$32.00	Buy
LZB La-Z-Boy	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley B. Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.63 -0.8%	$46.00 ➝ $40.00	Overweight
MAR Marriott International	Target Lowered by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robin Farley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$356.60 -0.9%	$412.00 ➝ $395.00	Neutral
MDB MongoDB	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$420.37 -4.6%	$400.00 ➝ $475.00	Buy
MDB MongoDB	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$420.37 -4.6%	$375.00 ➝ $500.00	Outperform
MFA MFA Financial	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kenneth S. Lee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.94 -1.8%	$10.00	Sector Perform
MIST Milestone Pharmaceuticals	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Olivia Brayer Saunders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03 -4.6%	$3.00	Overweight
MPWR Monolithic Power Systems	Target Set by	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1,310.60 +0.8%	$2,013.00	Buy
MRCY Mercury Systems	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alexandra Mandery Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.23 -6.9%	$109.00 ➝ $120.00	Buy
MRCY Mercury Systems	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Austin Moeller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$94.23 -6.9%	$106.00 ➝ $128.00	Buy
MRK Merck & Co., Inc.	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Evan David Seigerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.25 -1.9%	$142.00 ➝ $170.00	Outperform
MRK Merck & Co., Inc.	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Yee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.25 -1.9%	$145.00 ➝ $175.00	Buy
MRK Merck & Co., Inc.	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terence Flynn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.25 -1.9%	$116.00 ➝ $179.00	Equal Weight ➝ Overweight
MRK Merck & Co., Inc.	Downgraded by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trung Huynh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$149.25 -1.9%	$142.00 ➝ $150.00	Outperform ➝ Sector Perform
MRNA Moderna	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eliana Merle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.32 -23.5%	$50.00 ➝ $150.00	Neutral
MRNA Moderna	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Terence Flynn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$133.32 -23.5%	$39.00 ➝ $89.00	Equal Weight
MRT Marti Technologies	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Fawne Jiang Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.03 +3.6%	$5.00 ➝ $6.00	Buy
MRT Marti Technologies	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.03 +3.6%		Buy
MRT Marti Technologies	Target Set by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.03 +3.6%	$3.50
MRVL Marvell Technology	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%	$360.00	Outperform
MRVL Marvell Technology	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Timothy Arcuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%	$300.00 ➝ $310.00	Buy
MRVL Marvell Technology	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom O'Malley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%		Overweight
MRVL Marvell Technology	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%		Outperform
MRVL Marvell Technology	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$251.01 +5.8%	$250.00	Outperform
MRVL Marvell Technology	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%	$325.00	Buy
Buy These Stocks Before August 31st (Ad) Keith Kaplan has invested $17 million into his own AI research platform, now used by 180,000 investors worldwide. The analyst, who called the 2020 crash early, is working with a former NSA codebreaker and Pentagon insider on a new approach to AI stocks ahead of August 31. Investors like Stephen and Keith W. say the tools helped shape their portfolios, though results vary and are not typical. Get the full details on Keith Kaplan's AI stock research now
MRVL Marvell Technology	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Suji Desilva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$251.01 +5.8%	$350.00	Buy
MSGE Madison Square Garden Entertainment	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.75 -3.3%	$86.00	Neutral
NBP I-Mab	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.91 -3.5%	$9.00	Buy
NBR Nabors Industries	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Kutz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$91.41 -0.4%	$110.00
NDSN Nordson	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Summerville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.70 +8.0%	$345.00	Buy
NDSN Nordson	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey D. Hammond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.70 +8.0%		Buy
NDSN Nordson	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey D. Hammond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$334.70 +8.0%	$335.00 ➝ $360.00	Overweight
NHP National Healthcare Properties	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wesley Golladay Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$17.08 +1.2%	$17.00 ➝ $18.00	Outperform
NIQ NIQ Global Intelligence	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.19 -0.7%	$18.00 ➝ $21.00	Buy
NRGV Energy Vault	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Bagri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.75 -2.8%	$5.00 ➝ $6.00	Buy
NTNX Nutanix	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$66.33 +1.4%	$80.00	Buy
NU NU	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thiago Batista Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.20 -2.8%	$16.90 ➝ $18.20	Buy
NVDA NVIDIA	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.85 -0.3%	$265.00
NVDA NVIDIA	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.85 -0.3%		Outperform
NVDA NVIDIA	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Srini Pajjuri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.85 -0.3%	$300.00	Outperform
NVDA NVIDIA	Target Set by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.85 -0.3%	$340.00
NVNI Nvni Group	Downgraded by	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allen Klee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$1.03		Buy ➝ Hold
NXRT NexPoint Residential Trust	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$24.28 +0.9%		Market Perform
NXRT NexPoint Residential Trust	Reiterated by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Hecht Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.28 +0.9%		Market Perform
OKTA Okta	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.16 -5.0%	$125.00 ➝ $170.00	Overweight
OKTA Okta	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.16 -5.0%	$138.00 ➝ $162.00	Buy
OKTA Okta	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.16 -5.0%	$120.00 ➝ $168.00	Outperform
OKTA Okta	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.16 -5.0%		Buy
OKTA Okta	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$134.16 -5.0%	$115.00 ➝ $180.00	Overweight
OMG Omai Gold Mines	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$3.10 +5.1%	C$3.50 ➝ C$4.25
ONT Oxford Nanopore Technologies	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 150.56 +7.8%	GBX 195	Buy
OPRA Opera	Target Raised by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Naved Khan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.29 +0.9%	$27.00 ➝ $28.00	Buy
P Everpure	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$110.22 -1.6%	$140.00	Outperform
PANW Palo Alto Networks	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$349.56 -2.8%	$335.00 ➝ $415.00	Outperform
PCTY Paylocity	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jared Levine Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$152.36 +2.0%	$168.00 ➝ $177.00	Buy
PD PagerDuty	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joel Fishbein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.08 -0.7%	$11.00 ➝ $13.00	Buy
PGNY Progyny	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stan Berenshteyn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.96 +1.7%	$37.00	Overweight
PGR Progressive	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elyse Greenspan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.60 +1.5%	$198.00 ➝ $201.00	Underweight
PGR Progressive	Upgraded by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.60 +1.5%	$226.00 ➝ $250.00	Market Perform ➝ Outperform
PGR Progressive	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$220.60 +1.5%	$245.00	Buy
PI Impinj	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$159.73 -3.2%	$220.00	Outperform
PNTG The Pennant Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.00 -0.4%	$42.00 ➝ $44.00	Outperform
PONY Pony AI	Upgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.74 -1.1%		Neutral ➝ Outperform
POOL Pool	Reiterated by	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Grooms Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$190.33 -2.9%	$225.00	Overweight
PRQR ProQR Therapeutics	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Stranahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.27 +2.3%	$8.00	Buy
QBTS D-Wave Quantum	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.80 -2.7%	$35.00	Outperform
QNCX Quince Therapeutics	Initiated by	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$32.11 -7.1%	$68.00	Buy
RARE Ultragenyx Pharmaceutical	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whitney Ijem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.32 -3.5%	$81.00 ➝ $83.00	Buy
RARE Ultragenyx Pharmaceutical	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yigal Nochomovitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.32 -3.5%	$45.00 ➝ $58.00	Buy
RARE Ultragenyx Pharmaceutical	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Benjamin Burnett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.32 -3.5%	$45.00 ➝ $46.00	Overweight
RARE Ultragenyx Pharmaceutical	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kristen Kluska Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.32 -3.5%	$96.00 ➝ $103.00	Overweight
RBRK Rubrik	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Param Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.40 -2.4%		Outperform
RBRK Rubrik	Target Set by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Param Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.40 -2.4%	$120.00
RBRK Rubrik	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$97.40 -2.4%	$95.00 ➝ $120.00	Overweight
RERE ATRenew	Initiated by	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.09 -10.9%		Outperform
RLAY Relay Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.70 -5.0%	$28.00 ➝ $29.00	Buy
S SentinelOne	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Saket Kalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.92 -1.9%	$16.00 ➝ $22.00	Equal Weight
S SentinelOne	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Ruykhaver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.92 -1.9%	$24.00 ➝ $26.00	Overweight
S SentinelOne	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.92 -1.9%	$24.00 ➝ $28.00	Buy
SAIL SailPoint	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meta Marshall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.51 -3.5%	$18.00 ➝ $22.00	Overweight
SBAC SBA Communications	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brendan Lynch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$180.54 -1.0%	$245.00 ➝ $208.00	Overweight
SEZL Sezzle	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Peterson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$117.42 -1.3%	$172.00	Buy
SHOP Shopify	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$147.18 +0.4%	$175.00	Buy
SJM J. M. Smucker	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$123.18 +0.3%	$130.00 ➝ $142.00	Buy
SMTC Semtech	Target Set by	New Street Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$124.88 -0.4%	$230.00
SMTC Semtech	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cody Acree Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$124.88 -0.4%		Buy
SMTC Semtech	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$124.88 -0.4%	$155.00	Outperform
SNOW Snowflake	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$320.04 -1.5%	$300.00 ➝ $370.00	Buy
SNOW Snowflake	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$320.04 -1.5%		Buy
SNOW Snowflake	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Miller Jump Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$320.04 -1.5%	$300.00 ➝ $375.00	Buy
SPG Simon Property Group	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nicholas Yulico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$220.33 -1.3%	$220.00 ➝ $222.00	Sector Perform
SPHR Sphere Entertainment	Initiated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Callahan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$155.94 -2.4%	$185.00	Overweight
SPTX Seaport Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.03 -1.6%	$50.00	Buy
SRZN Surrozen	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lachlan Brown Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.50 -2.1%	$51.00	Outperform
STRL Sterling Infrastructure	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$520.53 -2.6%	$700.00
SXI Standex International	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Shlisky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$309.28 -1.1%	$350.00	Buy
TEAM Atlassian	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joel Fishbein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$174.91 +0.4%	$160.00 ➝ $185.00	Buy
TEM Tempus AI	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Massaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.65 +8.8%	$70.00 ➝ $80.00	Buy
TGB Taseko Mines	Initiated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.69 +2.6%		Buy
TGT Target	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$166.00 ➝ $178.00	Outperform
TGT Target	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bradley B. Thomas Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%		Sector Weight
TGT Target	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$148.00 ➝ $160.00	Neutral
TGT Target	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Oliver Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$155.00 ➝ $160.00	Hold
TGT Target	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kelly Bania Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$150.00 ➝ $160.00	Market Perform
TGT Target	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Feldman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$170.00 ➝ $182.00	Outperform
TGT Target	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Kelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$165.00 ➝ $185.00	Overweight
TGT Target	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$127.00 ➝ $161.00	Neutral
TGT Target	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.04 -0.6%	$150.00
TGT Target	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Heinbockel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$150.00 ➝ $175.00	Buy
TGT Target	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Krisztina Katai Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$150.00
TGT Target	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.04 -0.6%		Overweight
TGT Target	Reiterated by	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$158.04 -0.6%	$142.00	Neutral
TGT Target	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scot Ciccarelli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$147.00 ➝ $167.00	Hold
TGT Target	Target Set by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Greg Melich Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$170.00
TGT Target	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Lasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$166.00 ➝ $185.00	Buy
TGT Target	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Keith Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$146.00 ➝ $153.00	Neutral
TGT Target	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Peter Benedict Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$170.00
TGT Target	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zhihan Ma Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$158.04 -0.6%	$154.00	Market Perform
TH Target Hospitality	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.63 +3.5%	$22.00	Hold ➝ Buy
TIMB TIM	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$17.48 -1.7%	$22.00	Market Perform
TIN LON:TIN	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 105.50 -0.9%	GBX 151	Buy
TJX TJX Companies	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$190.00 ➝ $188.00	Overweight
TJX TJX Companies	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$182.00 ➝ $154.00	Buy ➝ Neutral
TJX TJX Companies	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Straton Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$181.00 ➝ $178.00	Overweight
TJX TJX Companies	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$197.00 ➝ $198.00	Buy
TJX TJX Companies	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Binetti Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$173.00	Outperform
TJX TJX Companies	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$190.00	Buy
TJX TJX Companies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$160.00 ➝ $140.00	Equal Weight
TJX TJX Companies	Reiterated by	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chuck Grom Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$140.76 -2.6%	$155.00	Buy ➝ Accumulate
TKO Taseko Mines	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		C$11.98 +2.4%	C$15.00	Buy
TLX Telix Pharmaceuticals	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Laura Sutcliffe Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.42 +2.5%		Buy
TLX Telix Pharmaceuticals	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Nierengarten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.42 +2.5%	$22.00	Outperform
TOL Toll Brothers	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Bettenhausen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.12 -2.3%	$165.00 ➝ $170.00	Buy
TOL Toll Brothers	Reiterated by	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$145.12 -2.3%	$191.00	Outperform
TOL Toll Brothers	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Lovallo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.12 -2.3%	$187.00 ➝ $195.00	Buy
TRUP Trupanion	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$30.68 -1.4%	$28.00 ➝ $29.00	Hold
TS Tenaris	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joe Laetsch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$52.64 -0.8%	$65.00 ➝ $60.00	Equal Weight
TX Ternium	Downgraded by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.24 +0.4%		Buy ➝ Hold
TZOO Travelzoo	Target Lowered by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.70 -2.6%	$23.00 ➝ $20.00	Buy
UHS Universal Health Services	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$172.76 +0.2%	$183.00	Sector Perform
UMBF UMB Financial	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anthony Elian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$145.86 -0.2%	$180.00	Overweight
UNCY Unicycive Therapeutics	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bruce Jackson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.45 -2.3%	$13.00 ➝ $15.00	Speculative Buy
VEEV Veeva Systems	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$250.44 -0.2%	$232.00 ➝ $276.00	Buy
VIK Viking	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Wieczynski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.14 -0.7%	$125.00 ➝ $120.00	Buy
VIV Telefonica Brasil	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.23 -2.3%	$14.00
W Wayfair	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.41 -4.1%	$125.00	Buy
WB Weibo	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.19 -4.0%		Hold
WB Weibo	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.19 -4.0%		Buy ➝ Neutral
WDAY Workday	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$197.32 -0.6%		Hold
WHD Cactus	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Gruber Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$69.27 -6.0%	$67.00 ➝ $75.00	Buy ➝ Neutral
WIX Wix.com	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ygal Arounian Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$82.39 +5.8%	$55.00 ➝ $80.00	Neutral
WMT Walmart	Downgraded by	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$103.84 -9.2%		Buy ➝ Accumulate
WOLF Wolfspeed	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Buchalter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.20 -9.9%	$25.00	Hold
WTW Willis Towers Watson Public	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Kligerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$341.15 +1.7%	$391.00 ➝ $455.00	Buy
XERS Xeris Biopharma	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Glen Santangelo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.60 -2.1%	$9.00 ➝ $12.00	Overweight
XMTR Xometry	Initiated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Devitt Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$83.12 -1.7%	$110.00	Buy
YETI YETI	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Grambling Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$43.88 -0.5%	$48.00 ➝ $49.00	Equal Weight
YSS York Space Systems	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ciarmoli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.23 -9.3%	$26.00 ➝ $14.00	Hold
ZM Zoom Communications	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Taylor McGinnis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$106.30 -1.1%	$105.00 ➝ $115.00	Neutral
ZTS Zoetis	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$75.13 -2.0%	$85.00 ➝ $80.00	Hold
ZVRA Zevra Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.89 -2.0%		Buy
ZVRA Zevra Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.89 -2.0%	$26.00	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 09:19 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings